We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Lipoprotein Receptor Mutation Linked to Increased Coronary Heart Disease Risk

By LabMedica International staff writers
Posted on 01 Jun 2015
Print article
A mutation caused by a single nucleotide polymorphism (SNP) in a cell membrane lipoprotein receptor has been linked to a significantly higher risk for developing coronary heart disease (CHD).

The lipoprotein receptor SR-BI (scavenger receptor class B, type I), which is encoded by the SCARB1 gene, is an integral membrane protein found in numerous cell types and tissues, including the liver and adrenal. It is best known for its role in facilitating the uptake of cholesteryl esters from high-density lipoproteins (HDL) in the liver. This process drives the movement of cholesterol from peripheral tissues towards the liver for excretion. This movement of cholesterol is known as reverse cholesterol transport and is a protective mechanism against the development of atherosclerosis, which is the principal cause of heart disease and stroke.

Investigators at the University of Connecticut (Farmington, USA) examined the association of the SCARB1 rs4238001 missense SNP with incidents of CHD. For this work incidences of CHD were identified in a population of 2,319 White, 1,570 African-American, and 1,292 Hispanic-American participants in the 2000–2002 Multi-Ethnic Study of Atherosclerosis in Major American Cities study. The association of rs4238001 with incident CHD was determined after adjustments for age, sex, principal components of ancestry, body mass index, diabetes status, serum creatinine, lipid levels, hypertension status, education, and smoking exposure.

Results published in the May 20, 2015, online edition of the journal PLOS ONE revealed that subjects who were carriers of the risk T allele for rs4238001 had significantly lower SR-BI protein levels as compared with carriers of the normal allele. Moreover, in vitro experiments showed that the rs4238001 variant was significantly associated with increased degradation of SR-BI protein and reduced function as measured by decreased specific cholesteryl ester uptake from HDL.

The clinical study showed that the SCARB1 missense SNP rs4238001 was statistically significantly associated with incident CHD across a large population of multiple race/ethnic groups. In particular men with the variant had a 29% higher risk than a comparable group of men without. African-American males fared even worse, with 49% increase risk, as compared to white males.

"We want to go deep in the cell, and figure out how to repair it," said senior author Dr. Annabelle Rodriguez-Oquendo, professor of cell biology at the University of Connecticut. "We are really interested in understanding more about how this protein gets chewed up and degraded faster."

Related Links:

University of Connecticut


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Hepato Fibrosis Assays
Hepato Fibrosis Assays
New
Automated Cell Counter
QuadCount

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The bowel cancer breakthrough could result in better treatment outcomes (Photo courtesy of 123RF)

New RNA Molecules Can Help Predict Bowel Cancer Return Recurrence

Colorectal cancer accounts for 10% of all cancer-related deaths worldwide and was ranked as the second most common cause of cancer death in the United States in 2022. Currently, clinicians face diagnostic... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image

AI-Based Method Shows Promise for Pathological Diagnosis of Hereditary Kidney Diseases

Alport syndrome is a hereditary kidney disorder characterized by kidney dysfunction, sensorineural hearing loss, and ocular abnormalities. Early in the disease, patients experience hematuria, which is... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.